Install
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
Diabetic Neuropathic Pain Clinical Trial Pipeline Analysis: 10+ Key Companies Shaping the Future of Diabetic Neuropathic Pain Therapeutics | DelveInsight
1+ week, 14+ hour ago (68+ words) Diabetic Neuropathic Pain Clinical Trial Pipeline Analysis: openPR.com Diabetic Neuropathic Pain Clinical Trial Pipeline Analysis: 10+ Key Companies Shaping the Future of Diabetic Neuropathic Pain Therapeutics | DelveInsight Press release from: DelveIinsight Business Research LLP Permanent link to this press release:…...
James T. Brunz, MD Recognized by Abbott Neuromodulation as a Spinal Cord Stimulation Center of Excellence Physician??? Ortho Spine News
2+ week, 6+ day ago (453+ words) TEA, S.D., Aug. 24, 2026 /PRNewswire/ — James T. Brunz, MD, an interventional spine and pain physician with Orthopedic Institute (OI), has been recognized by Abbott Neuromodulation as a Spinal Cord Stimulation (SCS) Center of Excellence physician based on his experience, clinical insights, and…...
Chemotherapy Induced Peripheral Neuropathy Treatment Market Analysis Highlights Growth To $2.36 Billion By 2030 At 6.2% CAGR
3+ week, 6+ day ago (63+ words) Chemotherapy Induced Peripheral Neuropathy Treatment Market openpr.com Chemotherapy Induced Peripheral Neuropathy Treatment Market Analysis Highlights Growth To $2.36 Billion By 2030 At 6.2% CAGR Press release from: The Business Research Company Permanent link to this press release: You can edit or delete…...